腹壁扩大切除联合重建术治疗腹壁侵袭性纤维瘤的临床疗效

Clinical efficacy of extended abdominal wall resection combined with reconstruction for abdo-minal wall aggressive fibromatosis

  • 摘要:
    探讨腹壁扩大切除联合重建术治疗腹壁侵袭性纤维瘤(AF)的临床疗效。
    采用回顾性描述性研究方法。收集2009年1月至2024年7月中国科学技术大学附属第一医院等全国3家医学中心收治的70例腹壁AF患者的临床资料;男6例,女64例;年龄为(36±13)岁。患者均行腹壁扩大切除联合重建术。观察指标:(1)手术情况。(2)肿瘤复发和术后并发症情况。偏态分布的计量资料组间比较采用Mann‑Whitney U检验。计数资料组间比较采用χ2检验。
    (1)手术情况。70例患者均施行腹壁扩大切除联合重建术,手术时间为90(91)min,术后住院时间为10(6)d。70例患者中,41例行腹壁AF切除+聚丙烯合成补片腹壁重建术,腹壁缺损面积为60(54)cm²,补片放置方式均为Sublay修补;29例患者行腹壁AF切除+直接缝合修补重建术,腹壁缺损面积为34(31)cm²。两者腹壁缺损面积比较,差异有统计学意义(U=291.00,P<0.05)。70例患者均获得R0切除,切缘距肿瘤边缘距离为2~3 cm 39例,切缘距肿瘤边缘距离>3 cm 31例。(2)肿瘤复发和术后并发症情况。70例患者术后均获得随访,随访时间为78(90)个月。随访期间,10例患者肿瘤复发(补片加强腹壁重建和直接缝合修补各5例),其中1例随访监测、1例行放疗,均未再行手术治疗;8例行再次手术R0切除后肿瘤未再复发。补片重建和直接缝合患者术后肿瘤复发比例比较,差异无统计学意义(χ2=0.06,P>0.05)。切缘距肿瘤边缘距离>3 cm患者术后肿瘤复发率为9.7%(3/31);切缘距肿瘤边缘距离2~3 cm患者肿瘤复发率为17.9%(7/39),两者比较,差异无统计学意义(χ2=0.97,P>0.05)。60例患者无肿瘤复发。随访期间,70例患者均未发生腹壁切口疝,2例发生术后切口感染,6例发生术后慢性疼痛。
    腹壁扩大切除联合重建术治疗腹壁AF安全、可行。

     

    Abstract:
    Objective To investigate the clinical efficacy of extended abdominal wall resec-tion combined with reconstruction for abdominal wall aggressive fibromatosis (AF).
    Methods The retrospective and descriptive study was conducted. The clinical data of 70 patients with abdominal wall AF who were admitted to 3 medical centers, including The First Affiliated Hospital of the University of Science and Technology of China, between January 2009 and July 2024 were collected. There were 6 males and 64 females, aged (36±13)years. All patients underwent extended abdominal wall resection combined with abdominal wall reconstruction. Observation indicators: (1) surgical situations; (2) tumor recurrence and postoperative complications. Comparisons of measurement data with skewed distribution between groups was conducted using the Mann‑Whitney U test. Comparison of count data between groups was conducted using the chi‑square test.
    Results (1)Surgical situations. All 70 patients underwent extended abdominal wall resection combined with abdominal wall recons-truction. The operation time was 90(91)minutes and duration of postoperative hospital stay was 10(6)days. Of the 70 patients, 41 patients underwent abdominal wall AF resection plus polypropylene mesh abdominal wall reconstruction, with a defect area of 60(54)cm². The mesh placement method was uniformly Sublay repair. The remaining 29 patients underwent abdominal wall AF resection plus direct suture repair, with a defect area of 34(31)cm². There was a significant difference in the abdominal wall defect area between the two groups (U=291.00, P<0.05). All 70 patients achieved R0 resection. The distance from surgical margin to tumor edge was 2-3 cm in 39 cases and >3 cm in 31 cases. (2) Tumor recurrence and postoperative complications. All 70 patients were followed up for 78(90)months. During follow‑up, 10 patients developed tumor recurrence (5 cases with mesh reinforced abdominal wall reconstruction and 5 cases with direct suture repair). Among them, one case was monitored, one case underwent radiotherapy, and neither received further surgical treatment. The remaining 8 patients underwent repeat R0 resection, and no further recurrence occurred. There was no significant difference in recurrence rate between the patients with mesh reconstruction and patients with direct suture repair (χ2=0.06, P>0.05). The postoperative recurrence rate was 9.7%(3/31) in patients with the distance from surgical margin to tumor edge >3 cm, versus 17.9%(7/39) in patients with the distance from surgical margin to tumor edge of 2-3 cm, showing no significant difference between them (χ2=0.97, P>0.05). Sixty patients had no tumor recurrence. During follow‑up, none of the 70 patients developed incisional hernia. Two patients experienced postoperative wound infection, and 6 cases developed postoperative chronic pain.
    Conclusion Extended abdominal wall resection combined with reconstruction is safe and feasible for abdominal wall AF.

     

/

返回文章
返回